Winston Roy
Former Officer at PCRX
- Sold, on record
- $3.3M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Aug 2, 2023
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PCRXPacira BioSciences, Inc.Former Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale PCRXUnusualJun 6 2022
Sold 17,546 shares at $61.39 ($1.1M)
Winston Roy, Chief Medical Officer
Sold 33.3% of holdings ($3.2M position)35,160 shares left3.5x usual sizeFiling
- 2 Form 4 sale PCRXPlan not statedAug 3 +58 days
Sold 476 shares at $55.70 ($27k)
Winston Roy, Chief Medical Officer
Sold 1% of holdings ($2.5M position)44,992 shares left0x usual sizeFiling
- 3 Form 144 notice PCRXNoticeJun 6 +307 days
Filed to sell 1,779 shares ($69k)
Winston Roy, Officer
No 10b5-1 planFiling
- 4 Form 144 notice PCRXNoticeJun 7 +1 day
Filed to sell 1,857 shares ($70k)
Winston Roy, Officer
No 10b5-1 planFiling
- 5 Form 4 sale PCRXNo planJun 7 same day
Sold 3,636 shares at $38.42 ($140k)
Winston Roy, Chief Medical Officer
No 10b5-1 planSold 8.1% of holdings ($1.7M position)41,356 shares leftFollows a Form 144Filing
- 6 Form 144 notice PCRXNoticeAug 2 +56 days
Filed to sell 509 shares ($18k)
Winston Roy, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 7 Form 4 sale PCRXNo planAug 2 same day
Sold 509 shares at $34.88 ($18k)
Winston Roy, Chief Medical Officer
No 10b5-1 planSold 1% of holdings ($1.8M position)52,440 shares left0.1x usual sizeFollows a Form 144Filing
- 8 Form 144 notice PCRXNoticeNov 13 +103 days
Filed to sell 31,000 shares ($876k)
Winston Roy, Former Officer
No 10b5-1 plan15x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | PCRX | Former Officer | Form 144 notice | 31,000 | $876k | Notice | SEC | |
| Aug 2, 2023 | PCRX | Chief Medical Officer | Form 4 sale | 509 | $18k | 1.0% | No plan | SEC |
| Aug 2, 2023 | PCRX | Officer | Form 144 notice | 509 | $18k | Notice | SEC | |
| Jun 7, 2023 | PCRX | Chief Medical Officer | Form 4 sale | 3,636 | $140k | 8.1% | No plan | SEC |
| Jun 7, 2023 | PCRX | Officer | Form 144 notice | 1,857 | $70k | Notice | SEC | |
| Jun 6, 2023 | PCRX | Officer | Form 144 notice | 1,779 | $69k | Notice | SEC | |
| Aug 3, 2022 | PCRX | Chief Medical Officer | Form 4 sale | 476 | $27k | 1.0% | Plan not stated | SEC |
| Jun 6, 2022 | PCRX | Chief Medical Officer | Form 4 sale | 17,546 | $1.1M | 33.3% | Unusual | SEC |
| Jun 4, 2021 | PCRX | Chief Clinical Officer | Form 4 sale | 2,276 | $139k | 8.7% | Plan not stated | SEC |
| Mar 31, 2021 | PCRX | Chief Clinical Officer | Form 4 sale | 22,224 | $1.6M | 45.8% | Unusual | SEC |
| Nov 13, 2020 | PCRX | Chief Clinical Officer | Form 4 sale | 5,000 | $310k | 12.6% | Plan not stated | SEC |
| Jun 4, 2019 | PCRX | Chief Clinical Officer | Form 4 sale | 722 | $31k | 4.2% | Plan not stated | SEC |